.svg)
With a Vision of Making Quality Healthcare Affordable Through Drug Delivery Solutions Focusing On Patient Convenience and Adherence, ZIM Labs' value proposition is its ability to provide a range of technology-based drug delivery solutions and non-infringing proprietary manufacturing processes for development, manufacture and supply of innovative and differentiated generic pharmaceutical and nutraceutical products to its customers globally.
Established in 1989. we are engaged In developing, manufacturing and supply of differentiated generic products In oral solid dosages alongside offering pre•formulation intermediates (PFI) and finished formulations (FF) for certain key therapeutic segments across rest of the world (RoW) markets. We are now focused on expanding our offerings
across two verticals - pharmaceuticals and nutraceuticals. to customers across the globe.
We offer a range of non-infringing drug delivery solutions based on process technologies that allow us to improve patient compliance thereby reducing the cost of treatment.
Our differentiation and value proposition is in our ability to develop and supply combination generic products using various drug delivery techniques and release patterns in the oral solid dosage form.
We partner with pharmaceutical and nutraceutical distribution companies who seek solutions for development, sourcing and marketing of differentiated generic products
FF business We register our products in select markets with plans to enter into marketing tie up with local distributors and marketing companies for launch of our FF products as branded generics
Part of FF business, it has been growing steadily over the years on the back of some high value pharmaceutical products and has recently ventured into Nutraceutical products
Established in 1989, we specialize in the development, manufacturing, and supply of differentiated generic products in oral solid dosage forms. Additionally, we offer Pre-Formulation Intermediates (PFI) and Finished Formulations (FF) across key therapeutic segments for Rest of the World (RoW) markets. With a focus on global expansion, we are diversifying our offerings across two key verticals: Pharmaceuticals and Nutraceuticals.
Our non-infringing drug delivery solutions leverage advanced process technologies to enhance patient compliance and reduce treatment costs.
Our unique value proposition lies in our expertise in developing and delivering combination generic products using innovative drug delivery techniques and various release patterns within oral solid dosage forms.
We collaborate with Pharmaceutical and Nutraceutical distribution companies seeking comprehensive solutions for the development, sourcing, and marketing of differentiated generic products.
In our Finished Formulations (FF) business, we focus on registering our products in select markets, with plans to establish marketing partnerships with local distributors and marketing companies to launch our FF products as branded generics.
As part of our Finished Formulations (FF) business, we have experienced steady growth over the years, driven by high-value Pharmaceutical products. Recently, we have expanded our portfolio to include Nutraceutical products, further strengthening our offerings.
We are dedicated to upholding values of integrity, innovation, and excellence, aiming to make a positive impact by providing accessible, high-quality healthcare solutions!
With a Vision of Making Quality Healthcare Affordable Through Drug Delivery Solutions
